择期经皮冠状动脉介入术中达肝素钠抗凝的剂量研究
陈学锋， 崔炜， 刘凡， 谷国强， 杨晓红， 谢瑞芹， 鲁静朝… - 临床荟萃, 2011 - cqvip.com
目的对比择期经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI)
术中使用不同剂量的达肝素钠对术后心肌损伤的影响, 探讨小剂量达肝素在PCI …
术中使用不同剂量的达肝素钠对术后心肌损伤的影响, 探讨小剂量达肝素在PCI …
Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin
TW Stief - Blood coagulation & fibrinolysis, 2006 - journals.lww.com
Low-molecular-weight heparins (LMWHs) are very important drugs; unfortunately, the
routine global hemostasis assays activated partial thromboplastin time and prothrombin time …
routine global hemostasis assays activated partial thromboplastin time and prothrombin time …
Anticoagulation in Acute Coronary Syndromes
SJ McRae, JW Eikelboom - New Therapeutic Agents in …, 2016 - taylorfrancis.com
Cardiovascular disease is the leading cause of death in the industrialized world and is
expected to become the single most common cause of morbidity and mortality in the …
expected to become the single most common cause of morbidity and mortality in the …